|
ИСТИНА |
Войти в систему Регистрация |
ИСТИНА ИНХС РАН |
||
Interstitial inflammation and pulmonary fibrosis in COVID-19: The potential role of cytostatic therapy for severe lung injuryстатья Электронная публикация
- Авторы: Filimonova Elena V., Davydova Lyubov A., Lysenko Mariana A., Tsarenko Sergey V.
- Журнал: RESPIRATORY MEDICINE CASE REPORTS
- Том: 38
- Год издания: 2022
- Номер статьи: 101676
- DOI: 10.1016/j.rmcr.2022.101676
- Аннотация: Highlights•Cyclophosphamide can be considered relatively safe and reasonably effective in severe lung damage in COVID-19.•Cyclophosphamide may reduce interstitial inflammation, thus preventing the development of pulmonary fibrosis.•No severe side effects were observed during low-dose cyclophosphamide therapy in our study
- Добавил в систему: Давыдова Любовь Алексеевна